ATE343574T1 - Ein thiazolidindionderivat und seine verwendung als antidiabetikum - Google Patents

Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Info

Publication number
ATE343574T1
ATE343574T1 AT01963244T AT01963244T ATE343574T1 AT E343574 T1 ATE343574 T1 AT E343574T1 AT 01963244 T AT01963244 T AT 01963244T AT 01963244 T AT01963244 T AT 01963244T AT E343574 T1 ATE343574 T1 AT E343574T1
Authority
AT
Austria
Prior art keywords
antidiabetic drug
compound
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
AT01963244T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE343574T1 publication Critical patent/ATE343574T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01963244T 2000-09-07 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum ATE343574T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021978.2A GB0021978D0 (en) 2000-09-07 2000-09-07 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ATE343574T1 true ATE343574T1 (de) 2006-11-15

Family

ID=9899043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963244T ATE343574T1 (de) 2000-09-07 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (15)

Country Link
US (1) US20040014791A1 (de)
EP (1) EP1315721B1 (de)
JP (1) JP2004508367A (de)
KR (1) KR100769007B1 (de)
CN (2) CN100415741C (de)
AT (1) ATE343574T1 (de)
AU (1) AU2001284274A1 (de)
CY (1) CY1105903T1 (de)
DE (1) DE60124119T2 (de)
DK (1) DK1315721T3 (de)
ES (1) ES2272528T3 (de)
GB (1) GB0021978D0 (de)
HK (1) HK1057204A1 (de)
PT (1) PT1315721E (de)
WO (1) WO2002020517A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
ATE318138T1 (de) * 1998-06-30 2006-03-15 Takeda Pharmaceutical Pharmazeutisches mittel zur behandlung von diabetes

Also Published As

Publication number Publication date
ES2272528T3 (es) 2007-05-01
KR20030031179A (ko) 2003-04-18
CN100415741C (zh) 2008-09-03
EP1315721A1 (de) 2003-06-04
CN1471530A (zh) 2004-01-28
EP1315721B1 (de) 2006-10-25
CN1814599A (zh) 2006-08-09
CY1105903T1 (el) 2011-02-02
GB0021978D0 (en) 2000-10-25
KR100769007B1 (ko) 2007-10-22
DK1315721T3 (da) 2007-02-19
JP2004508367A (ja) 2004-03-18
WO2002020517A1 (en) 2002-03-14
PT1315721E (pt) 2007-01-31
AU2001284274A1 (en) 2002-03-22
DE60124119T2 (de) 2007-05-16
DE60124119D1 (de) 2006-12-07
HK1057204A1 (en) 2004-03-19
US20040014791A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
ATE343574T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
ATE329914T1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
DE60217168D1 (de) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
AP1813A (en) Tartrate salts of thiazolidinedione derivative.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315721

Country of ref document: EP

REN Ceased due to non-payment of the annual fee